454 Using Upcoming Version of Sequencing Platform in Perlegen Drug-Response Project | GenomeWeb
Perlegen Sciences will be among the first to get a glimpse of an updated version of 454 Life Sciences’ sequencing platform, which will offer longer reads and higher throughput than the current FLX system, In Sequence has learned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.